Sotac Pharmaceuticals Ltd share price logo

Sotac Pharmaceuticals Ltd Share Price

NSE: SOTAC

BSE: 78648

Small Cap

Healthcare Sector

₹125.00

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Sotac Pharmaceuticals Ltd Stock Performance

as on October 13, 2025 at 4:01 pm IST

  • Day's Low

    ₹118.75
    ₹125
    downward going graph

    5.00%

    Downside

  • 52 Week's Low

    52 Week's High

    ₹88.05
    ₹152.35
    downward going graph

    29.56%

    Downside

    21.88%

    Upside

    downward going graph

Sotac Pharmaceuticals Ltd share price movements today

Previous Close
₹125.00
Open
₹118.75
Volume
3,600.00
Upper Circuit
₹131.25
Lower Circuit
₹118.75
Day's Low - High
₹118.75 - ₹125
52 Week Low - High
₹88.05 - ₹152.35

Sotac Pharmaceuticals Ltd Historical Returns

1 Month Return
+ 1.63 %
3 Month Return
+ 0.81 %
1 Year Return
-13.19 %
3 Year Return
+ 3.52 %
5 Year Return
+ 3.52 %

Sotac Pharmaceuticals Ltd Fundamentals

as on October 13, 2025 at 4:01 pm IST

Market Cap

₹138.13 Cr

Return on Equity (ROE)

9.42

PE Ratio (TTM)

30.86

Return on capital employed (ROCE)

11.41

Industry PE ratio

41.61

Beta (LTM)

0.85

P/B Ratio

2.47

Dividend Yield

0

PEG Ratio

52.31

Quarterly Earnings Growth YOY

100

EPS (TTM)

8.39

Sector

Pharmaceuticals

Book Value

48.19

Technical Analysis

Bullish

View Technical Analysis

Sotac Pharmaceuticals Ltd Stock Valuation

as on October 13, 2025 at 4:01 pm IST

Sotac Pharmaceuticals Ltd in the last 5 years

  • Overview

  • Trends

Lowest (13.14x)

April 24, 2023

Today (30.86x)

October 10, 2025

Industry (41.61x)

October 10, 2025

Highest (44.90x)

July 16, 2024

LowHigh

Today’s Price to Earnings Ratio: 30.86x

Sotac Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sotac Pharmaceuticals Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Sotac Pharmaceuticals Ltd image
Sotac Pharmaceuticals Ltd
NA138.130.7%0.74996
Source Natural Foods & Herbal Supplements Ltd image
Source Natural Foods & Herbal Supplements Ltd
NA88.772.06%0.00244
Syncom Formulations (India) Ltd image
Syncom Formulations (India) Ltd
NA1,597.06203.55%0.5149465
Murae Organisor Ltd image
Murae Organisor Ltd
NA75.66-17.26%0.007854
Bal Pharma Ltd image
Bal Pharma Ltd
NA132.305.55%0.847303
See all

Sotac Pharmaceuticals Ltd Stock’s Investor Sentiment and Interest

Search interest for Sotac Pharmaceuticals Ltd Stock has increased by 47% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:47% versus previous 30 day period

Sotac Pharmaceuticals Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Sales
19.65
18.08
24.97
26.67
25.74
26.45
25.25
27.35
Other Income
0.01
0.14
0.23
0.05
0.61
0.35
0.25
0.45
Total Income
19.66
18.22
25.2
26.73
26.35
26.8
25.5
27.8
Expenses
17.88
15.67
22.63
24.59
23.06
25.27
23.03
25.24
Operating Profit
1.77
2.41
2.34
2.08
2.68
1.18
2.22
2.11
Operating Profit Margin %
9.01%
13.33%
9.37%
7.8%
10.41%
4.46%
8.79%
7.71%
Profit Before Interest, Tax and Depreciation
1.78
2.55
2.57
2.14
3.29
1.53
2.46
2.56
Interest
0.27
0.64
0.46
0.67
0.99
0.35
0.42
0.6
Depreciation
0.56
0.61
0.6
0.78
0.83
0.88
0.75
0.74
Profit Before Tax
0.95
1.3
1.51
0.69
1.47
0.3
1.29
1.22
Tax Paid
0.37
0.27
0.52
0.47
0.59
-1.21
-0.05
0.79
Profit After Tax
0.58
1.04
0.98
0.21
0.88
1.51
1.35
0.42
Total Net profit including share of profit / Loss from associate company
0.58
1.04
1.08
0.65
0.91
1.65
1.46
0.46
EPS
0.29
1.58
1.01
0.58
0.82
1.49
1.32
0.42
Actual EPS
0.29
1.58
1.01
0.58
0.82
1.49
1.32
0.42
Adjusted EPS
0.29
1.58
1.01
0.58
0.82
1.49
1.32
0.42
Diluted EPS
0.29
1.58
1.01
0.58
0.82
1.49
1.32
-

Sotac Pharmaceuticals Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2020
Mar 2021
Mar 2023
Mar 2024
Mar 2025
Sales
28.6
48.84
77.48
103.83
96.99
Other Income
0.22
0.11
0.93
0.49
3.9
Total Income
28.83
48.95
78.41
104.32
100.88
Expenses
26.74
47.39
70.23
95.55
83.35
Operating Profit
1.86
1.45
7.25
8.28
13.64
Operating Profit Margin %
6.5%
2.97%
9.36%
7.97%
14.06%
Profit Before Interest, Tax and Depreciation
2.08
1.56
8.18
8.77
17.53
Interest
0.33
1.02
1.98
1.7
2.58
Depreciation
1.4
2.59
2.28
3.1
3.84
Profit Before Tax
0.35
-2.05
3.92
3.97
11.11
Tax Paid
0.27
0.31
1.64
0.39
1.85
Profit After Tax
0.09
-2.37
2.29
3.58
9.28
Total Net profit including share of profit / Loss from associate company
0.09
-2.37
2.88
4.28
8.03
EPS
0.89
-10.28
3.58
3.9
7.26
Actual EPS
0.89
-10.28
3.58
3.9
7.26
Adjusted EPS
0.25
-2.94
3.58
3.9
7.26
Diluted EPS
0.89
-10.28
3.58
3.9
7.26

Sotac Pharmaceuticals Ltd Cash Flow

Figures in Rupees Crores

Mar 2020
Mar 2021
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
0.06
-0.31
8.14
-16.08
-4.33
Cash Flow from Investing Activities
-11.75
-3.23
-11.67
-14.59
-18.55
Cash Flow from Financing Activities
11.4
3.38
13.14
29.49
16.09
Net Cash Flow
-0.29
-0.16
9.61
-6.26
-1.85

Sotac Pharmaceuticals Ltd Stock Shareholding Pattern

Numbers in percentages

Apr 2023
Sep 2023
Mar 2024
Sep 2024
Mar 2025
Promoters
72.85%
72.85%
72.85%
72.85%
72.85%
Public
14.27%
18.64%
18.16%
18.27%
11.35%
Total Outstanding Shares
1,10,50,000
1,10,50,000
1,10,50,000
1,10,50,000
1,10,50,000
Total Shareholders
784
255
245
251
243

Sotac Pharmaceuticals Ltd Corporate Actions

View detailed summary of the earnings and dividend history of Sotac Pharmaceuticals Ltd.

  • Sotac Pharmaceuticals Ltd Earnings Results

    Sotac Pharmaceuticals Ltd’s net profit fell -29.23% since last year same period to ₹0.46Cr in the Q2 2024-2025. On a quarterly growth basis, Sotac Pharmaceuticals Ltd has generated -68.28% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Sotac Pharmaceuticals Ltd Dividends May,2025

    In the quarter ending March 2025, Sotac Pharmaceuticals Ltd has declared dividend of ₹0.10 per share on 28 May 2025 - translating a dividend yield of 0.08%.

    Read More about Dividends

Insights on Sotac Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 25.5 Cr → 27.8 Cr (in ₹), with an average increase of 8.3% per quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 8.88% to 15.12% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, SOTAC stock has moved up by 10.1%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 72.85% of holdings in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 1.64 Cr → 0.46 Cr (in ₹), with an average decrease of 39.9% per quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 18.27% to 11.35% in Mar 2025 quarter

About Sotac Pharmaceuticals Ltd

Sotac Pharmaceuticals Limited is a part of the Gujarat based SOTAC Group, offering a range of products such as tablets, capsules, oral liquids, and external preparations. Their therapeutic portfolio includes options for treating ailments such as diabetes, psychotics, vitamins, minerals, cold, allergies, ulcers, and more. They started off as a Partnership Firm in October 2015 and have since then evolved into a Public Limited Company. Their installed capacity for manufacturing is 90 crore tables and 14 crore capsules per year. In 2022, they acquired two subsidiary companies and started a new venture called SOTAC Lifescience Private Limited, raising 51 percent of total paid-up capital. They are planning to come out with a Initial Public Offer consisting of up to 3 million equity shares through a fresh issue.

Revenue: ₹27.35Cr as on September 2024 (Q2 FY25)
Net Profit: ₹0.42Cr as on September 2024 (Q2 FY25)
Listing date: 13 Apr, 2023
Chairperson Name: Sharadkumar Dashrathbhai Patel
OrganisationSotac Pharmaceuticals Ltd
IndustryPharmaceuticals
CEOSharadkumar Dashrathbhai Patel
E-voting on sharesClick here to vote

FAQs

What is Sotac Pharmaceuticals Ltd share price today?

Sotac Pharmaceuticals Ltd share price today stands at ₹125 as on at the close of the market. Sotac Pharmaceuticals Ltd share today touched a day high of ₹125 and a low of ₹118.75.

What is the 52 week high and 52 week low range for Sotac Pharmaceuticals Ltd share?

Sotac Pharmaceuticals Ltd touched a 52 week high of ₹152.35 and a 52 week low of ₹88.05. Sotac Pharmaceuticals Ltd share price today i.e. is closed at ₹125, which is -17.95% down from its 52 week high and 41.96% up from its 52 week low.

What is Sotac Pharmaceuticals Ltd's market capitalisation today?

Sotac Pharmaceuticals Ltd market capitalisation is ₹138.13 Cr as on .

How to buy Sotac Pharmaceuticals Ltd shares?

To buy Sotac Pharmaceuticals Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for SOTAC or Sotac Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Sotac Pharmaceuticals Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Sotac Pharmaceuticals Ltd trading volume today?

Sotac Pharmaceuticals Ltd trading volume is 3,600.00 as on . This means that 3,600.00 shares of Sotac Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.